Skye Bioscience

0 followers


Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.

Industries

Headquarters

Stage

Employees

Links

Org chart

Punit Dhillon

Collapse
Kaitlyn Arsenault
Chief Financial Officer
Tu Diep
Chief Development Officer
Chris Twitty
Chief Scientific Officer
Karam Takhar
VP, Corporate Development & Investor Relations